Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPE trial of colesevelam versus placebo for cholestatic pruritus
NL-OMON31774Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2008
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholestatic pruritus comparing Colesevelam with Placebo (2 arms). Started Sep 2008; status: recruiting.
02
Drugs
colesevelam
03
Conditions
cholestatic pruritus
Beyond the preview
Go deeper on NL-OMON31774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31774.